8-K: Brighthouse Financial to Be Acquired for $4.1B

Brighthouse Financial announced a definitive merger agreement to be acquired by an affiliate of Aquarian Capital LLC for $70.00 per share in an all-cash transaction.

Summary

• Brighthouse Financial entered a definitive merger agreement to be acquired by an affiliate of Aquarian Capital LLC for $70.00 per share in an all-cash transaction, valuing the company at approximately $4.1 billion.
• Reported net income available to shareholders of $453 million, or $7.89 per diluted share, for Q3 2025, significantly up from $150 million, or $2.47 per diluted share, in Q3 2024.
• Adjusted earnings, less notable items, were $261 million, or $4.54 per diluted share, for Q3 2025, compared to $243 million, or $3.99 per diluted share, in Q3 2024.
• The estimated combined risk-based capital (RBC) ratio was between 435% and 455% at September 30, 2025, at the upper end of its target range of 400% to 450%.
• Holding company liquid assets stood at $1.0 billion at the end of Q3 2025.
• Annuity sales increased to $2.7 billion, primarily driven by record sales of Shield Level Annuities.
• Life sales increased to $38 million, primarily driven by sales of Brighthouse SmartCare.
• Book value was $4.7 billion ($81.60 per common share), and book value excluding accumulated other comprehensive income (AOCI) was $8.7 billion ($151.94 per common share) at September 30, 2025.
• The Q3 2025 results included a net favorable impact to net income of $316 million from the GAAP annual actuarial review, which increased the long-term mean reversion interest rate assumption for the 10-year U.S. Treasury from 4.00% to 4.50%.

Sentiment

Score: 8

Explanation: The announcement of an all-cash acquisition at a premium price, combined with strong Q3 financial results and a robust capital position, indicates a very positive outlook for shareholders. The favorable actuarial review further strengthens the financial picture. While there are standard merger-related risks, the overall sentiment is highly positive due to the definitive nature of the transaction and solid performance.

Positives

• Net income available to shareholders significantly increased to $453 million ($7.89 per diluted share) in Q3 2025 from $150 million ($2.47 per diluted share) in Q3 2024.
• Adjusted earnings, less notable items, increased to $261 million ($4.54 per diluted share) in Q3 2025 from $243 million ($3.99 per diluted share) in Q3 2024.
• The estimated combined RBC ratio of 435%-455% is at the upper end of the target range (400%-450%) and benefited from the successful separation of legacy VA and first-generation Shield business.
• Annuity sales grew 8% quarter-over-quarter and 5% sequentially to $2.7 billion, driven by record sales of Shield Level Annuities.
• Life sales increased 27% quarter-over-quarter, 15% sequentially, and 23% year-to-date through Q3 2025.
• Book value per common share increased to $81.60 from $63.94 year-over-year.
• Book value per common share, excluding AOCI, increased to $151.94 from $132.91 year-over-year.
• A net favorable impact of $316 million to net income resulted from the GAAP annual actuarial review, including an increased long-term mean reversion interest rate assumption for the 10-year U.S. Treasury from 4.00% to 4.50%.
• Holding company liquid assets of $1.0 billion.

Negatives

• Corporate expenses slightly increased to $205 million in Q3 2025 from $203 million in Q3 2024.
• Adjusted earnings in the Annuities segment decreased to $304 million in Q3 2025 from $327 million in Q3 2024.
• Third quarter year-to-date total annuity sales decreased 3% compared to the same period in 2024, despite strong Shield Level Annuity sales.

Risks

• Differences between actual experience and actuarial assumptions and the effectiveness of actuarial models.
• Higher risk management costs and exposure to increased market risk due to guarantees within certain products.
• The effectiveness of risk management strategy and its impacts on volatility in profitability measures and negative effects on statutory capital.
• Material differences between actual outcomes and the sensitivities calculated under certain scenarios utilized in risk management strategies.
• The impact of interest rates on future ULSG policyholder obligations and net income volatility.
• The potential material adverse effect of changes in accounting standards, practices, or policies.
• Loss of business and other negative impacts resulting from a downgrade or a potential downgrade in financial strength or credit ratings.
• The availability of reinsurance and the ability of counterparties to reinsurance or indemnification arrangements to perform their obligations.
• Heightened competition, including with respect to service, product features, product mix, scale, price, actual or perceived financial strength, claims-paying ratings, credit ratings, e-business capabilities, and name recognition.
• Ability to market and distribute products through distribution channels and maintain relationships with key distribution partners.
• Any failure of third parties to provide services needed, any failure of their practices and procedures, and any inability to obtain information or assistance from them.
• The ability of subsidiaries to pay dividends to the company, and the company's ability to pay dividends to shareholders and repurchase common stock.
• The risks associated with climate change.
• The adverse impact of public health crises, extreme mortality events, or similar occurrences on business and the economy in general.
• The impact of adverse capital and credit market conditions, including with respect to liquidity needs and access to capital.
• The impact of economic conditions in the capital markets and the U.S. and global economy, as well as geopolitical events, tariffs, military actions, or catastrophic events, on profitability measures and investment portfolio.
• The financial risks that the investment portfolio is subject to, including credit risk, interest rate risk, inflation risk, market valuation risk, liquidity risk, real estate risk, and derivatives risk.
• The impact of changes in regulation and in supervisory and enforcement policies or interpretations thereof on insurance business or other operations.
• The potential material negative tax impact of potential future tax legislation.
• The effectiveness of policies, procedures, and processes in managing risk.
• The loss or disclosure of confidential information, damage to reputation, and impairment of ability to conduct business effectively as a result of any failure in cyberor other information security systems.
• Whether all or any portion of the tax consequences of the separation from MetLife, Inc. are not as expected, leading to material additional taxes or adverse consequences to tax attributes.
• Ability to complete the merger on the timeframe or in the manner currently anticipated or at all, including due to a failure to obtain the regulatory approvals required for the closing of the merger or the occurrence of any event, change, or other circumstance that could give rise to the right of one or both parties to terminate the merger agreement.
• The effect of the pendency of the merger on ongoing business and operations, including disruption to business relationships, the diversion of management's attention from ongoing business operations and opportunities, or the outcome of any legal proceedings that may be instituted against Aquarian Capital or Brighthouse Financial following announcement of the merger.
• Restrictions on the conduct of business prior to the closing of the merger and on ability to pursue alternatives to the merger.
• The possibility that the merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events.

Future Outlook

The company anticipates volatility in net income (loss) due to differences between its hedge target and GAAP reserves. It is currently conducting its 2025 statutory annual actuarial review, which is expected to result in an increase to statutory reserves. Despite this, the company expects to remain within its combined RBC ratio target range of 400% to 450% in normal market conditions at year-end 2025, without contributing capital to its insurance subsidiaries. The merger with Aquarian Capital is expected to deliver value to stockholders and position the company for continued growth, though its completion is subject to regulatory approvals and other conditions.

Management Comments

• "Brighthouse Financial delivered solid results in the quarter as we continued to execute our strategy."
• "In addition to producing strong sales, including achieving another record quarter for sales of our flagship Shield annuity products, we completed the separation of our legacy VA and first-generation Shield business, and ended the quarter with an estimated combined RBC ratio of 435% to 455%, at the upper end of our target range of 400% to 450% in normal market conditions."
• "We believe the transaction with Aquarian Capital that we announced today will deliver clear and compelling value to our stockholders, while positioning Brighthouse Financial to continue pursuing growth opportunities and advancing our mission of helping people achieve financial security."

Industry Context

The acquisition of Brighthouse Financial by Aquarian Capital reflects ongoing consolidation and strategic repositioning within the U.S. life insurance and annuity sector. Companies are seeking to optimize portfolios, enhance capital efficiency, and leverage specialized expertise. Brighthouse's focus on annuities and life insurance, particularly its Shield Level Annuities, aligns with a broader industry trend of offering products designed for financial security in volatile markets. The strong RBC ratio and successful business separation indicate a healthy underlying business being acquired, which could be attractive in a market where capital strength is paramount.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for direct industry standard comparisons.
• The estimated combined RBC ratio of 435%-455% is at the upper end of the company's internal target range of 400%-450%, suggesting strong capital adequacy relative to its own benchmarks.
• The acquisition price of $70.00 per share and total value of $4.1 billion can be compared to recent M&A multiples in the insurance sector, but such analysis is not provided within the filing itself.

Legal Proceedings

• The filing mentions 'the outcome of any legal proceedings that may be instituted against Aquarian Capital or Brighthouse Financial following announcement of the merger' as a risk factor.

Stakeholder Impact

• Shareholders: Will receive $70.00 per share in cash, representing a clear and compelling value. The merger is highly likely to significantly influence the share price.
• Employees: The filing does not explicitly mention the impact on employees, but mergers often lead to organizational changes.
• Customers: The company aims to continue pursuing growth opportunities and advancing its mission of helping people achieve financial security, implying continuity of service.
• Creditors: The company's strong RBC ratio and liquid assets suggest continued financial stability, which is positive for creditors.
• Suppliers: No direct impact mentioned, but business continuity is implied.

Next Steps

• Complete the merger with Aquarian Capital LLC, subject to regulatory approvals.
• Continue conducting the 2025 statutory annual actuarial review.
• Maintain the combined RBC ratio within the 400% to 450% target range at year-end 2025.

Key Dates

Recommendation

Given the definitive merger agreement for an all-cash transaction at $70.00 per share, existing shareholders should hold their shares to receive the acquisition price upon closing. If the current market price is below $70.00, holding allows for the realization of the premium. The strong Q3 results and capital position further support holding through the merger process, assuming the deal closes as expected.

Keywords

Brighthouse Financial, BHF, Aquarian Capital, Merger, Acquisition, Financial Results, Q3 2025, Annuities, Life Insurance, RBC Ratio, Book Value, Actuarial Review, Financial Services, Insurance, Investment